Pfanstiehl Labs
This article was originally published in The Tan Sheet
Executive Summary
Supplement ingredient supplier acquired by Ferro Corp. Oct. 31. Terms were not disclosed; the companies hope to complete the transaction during the fourth quarter. Ferro, which makes industrial coatings, chemicals and plastics, said the market for independently produced fine chemicals "is growing rapidly, in part because of the ongoing trend at pharmaceutical companies to outsource chemical production and to instead focus on drug discovery and marketing." Pfanstiehl is supplying glucosamine for an NIH-funded study on osteoarthritis (1"The Tan Sheet" Sept. 4, p. 4)
You may also be interested in...
Glucosamine/Chondroitin Supplier Selection Delays NIH Study
Difficulty in choosing a U.S. company to supply glucosamine and chondroitin sulfate has delayed the start of the NIH-funded study on osteoarthritis.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands